Experience

Davis Polk advised the representatives of the underwriters in connection with an initial public offering of Inventiva S.A.’s 7,478,261 American Depositary Shares. Aggregate gross…

Davis Polk advised XP Inc. in connection with an SEC-registered secondary offering of 22,465,733 Class A common shares by certain selling shareholders at a price per Class A common share of…

Davis Polk advised an ad hoc group (the “Ad Hoc Group”) of prepetition secured term lenders and DIP term lenders in connection with the chapter 11 cases of McDermott International, Inc. and…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the $192.5 million offering of common stock of Constellation…

Davis Polk advised the underwriters in connection with the initial public offering of 51,750,000 units of Trebia Acquisition Corp., including 6,750,000 units purchased pursuant to the…

Davis Polk is advising Novo Nordisk A/S on its acquisition of Corvidia Therapeutics Inc. for an upfront payment of $725 million in cash. Total payments to Corvidia Therapeutics shareholders…

Davis Polk advised the representatives of the several underwriters, in connection with the initial public offering of 103,500,000 units of Foley Trasimene Acquisition Corp., including…

Davis Polk advised the underwriters in connection with the offering of $1.75 billion aggregate principal amount of 1.050% bonds due May 21, 2027 issued by the Province of Ontario. The Davis…

Davis Polk advised the underwriters in connection with the offering of $2.25 billion aggregate principal amount of 1.000% bonds due May 20, 2025, issued by the Province of Alberta. The…

Davis Polk advised the representatives of the several underwriters in connection with the $13.3 billion secondary offering of 31,628,573 shares of common stock of BlackRock, Inc. by a…